Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank36
Studio
Year-over-Year Change

Debt-to-equity ratio

Percentile
P36
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
2025-0.10+95.1%
2024-2.06-8160.7%
2023-0.02-106.2%
20220.40-74.2%
20211.57+179.8%
2020-1.96-185.5%
20192.30+158.2%
2018-3.95-1071.9%
20170.41+85.3%
20160.22-